Healthcare Law Blog
DECEMBER 15, 2022
Specifically, CMS proposes that, beginning January 1, 2026, impacted payers would be required to: Implement and maintain a FHIR PARDD API using technology conformant with certain standards and implementation specifications in 45 CFR 170.215. CMS is not proposing to apply these requirements to drugs that are covered by the MAO.
Healthcare Law Blog
AUGUST 25, 2022
The first list of up to 10 Part D negotiation-eligible drugs will be published in 2026, the earliest “price applicability date” at which the Program takes effect. The drug publication date for 2026 will be chosen by September 1, 2023. Additional updates of note include: ACA Premium Tax Credit Eligibility. Other Updates.
Hall Render
JANUARY 27, 2023
to revisit whether to set limits for numbers of patients assigned to a nurse Tufts spent $70M on EHR install Wait times for long-term psychiatric care span months for some patients Health care leaders applaud appointment of Kate Walsh as Massachusetts health secretary As ER waits stretch for days, Mass.
Expert insights. Personalized for you.
52 
Let's personalize your content